| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -532,831 | -1,618,887 | -221,304 | -1,357,921 |
| Depreciation and amortization | 5,872 | 5,522 | 2,721 | 13,341 |
| Stock compensation expense | 12,000 | 376,000 | NaN | NaN |
| Common stock for services | NaN | NaN | 67,500 | NaN |
| Common stock issued for services | NaN | 135,000 | NaN | NaN |
| Increase in allowance for uncollectible accounts | 20,000 | NaN | NaN | NaN |
| Accounts receivable | 508,612 | -1,067,387 | -42,371 | 88,822 |
| Inventory | 12,016 | -11,558 | -27,409 | 126,805 |
| Deferred cost of goods | 3,234 | -120,798 | -250,654 | -18,905 |
| Right of use asset | -10,538 | -10,320 | -10,104 | -13,301 |
| Other current assets | 386,488 | -12,098 | 9,418 | -106,368 |
| Other assets | 76,798 | -8,501 | 6,505 | -6,233 |
| Increase in accounts and other payables | 553,253 | -302,342 | -469,876 | -38,080 |
| Lease liability | -8,804 | -10,876 | -10,662 | -4,594 |
| Net cash used in operating activities | -927,120 | -252,421 | -317,006 | -1,458,074 |
| Purchase of property and equipment | NaN | NaN | NaN | 1,201 |
| Net cash used in investing activities | NaN | NaN | NaN | -1,201 |
| Payments on short-term debt, net | NaN | NaN | 335,520 | NaN |
| Proceeds from short-term debt | NaN | NaN | -29,871 | 102,500 |
| Payments on short-term notes payable/debt | NaN | -858,591 | -53,245 | -7,261 |
| Proceeds from short-term notes payable/debt | NaN | 651,572 | NaN | NaN |
| Payments on short-term debt, net | 159,500 | NaN | NaN | NaN |
| Proceeds from (payments on) long-term debt | -38,745 | -104,763 | NaN | NaN |
| Common stock issued, net of cost of financing | 1,624,684 | 2,224,048 | 2,482,751 | 223,595 |
| Net cash provided by financing activities | 1,426,439 | 2,175,157 | 2,064,115 | 318,834 |
| Effect of exchange rate changes on cash | -24,155 | -34,066 | -43,468 | 108,575 |
| Net decrease in cash, restricted cash and cash equivalents | 475,164 | 1,888,670 | 1,704,842 | -1,031,866 |
| Cash, restricted cash and cash equivalents- beginning of period | 5,219,946 | 3,331,276 | 2,658,300 | NaN |
| Cash, restricted cash and cash equivalents - end of period | 5,695,110 | 5,219,946 | 3,331,276 | NaN |
Iveda Solutions, Inc. (IVDA)
Iveda Solutions, Inc. (IVDA)